Predictors of atrial antitachycardia pacing efficacy in patients affected by Brady-Tachy form of sick sinus syndrome and implanted with a DDDRP Device

Journal of Cardiovascular Electrophysiology

Volumn 16, Issue 7, 2005, Pages 714-723

  Boriani, Giuseppe ^a   Padeletti, Luigi ^b   Santini, Massimo ^c   Gulizia, Michele ^d   Capucci, Alessandro ^e   Botto, Gianluca ^f   Ricci, Renato ^c   Molon, Giulio ^g   Accogli, Michele ^h   Vicentini, Alfredo ⁱ   Biffi, Mauro ^a   Vimercati, Marco ^j   Grammatico, Andrea ^j  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d Department of Cardiology   (Italy)

^e Civile Hospital   (Italy)

^f SANT ANNA HOSPITAL   (Italy)

^g S Cuore Hospital   (Italy)

^h Panico Hospital   (Italy)

ⁱ Casa di Cura Pederzoli ^*  (Italy)

^j Clinical Department   (Italy)

more..

Author keywords

Antitachycardia pacing; Atrial fibrillation; Termination efficacy predictors

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM PACING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; SICK SINUS SYNDROME; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; COHORT STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SICK SINUS SYNDROME; TREATMENT OUTCOME;

EID: 22244443818     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2005.40716.x     Document Type: Article

References (43)

1. Ryder KM, Benjamin EJ: Epidemiology and significance of atrial fibrillation. Am J Cardiol 1999;84:131R-138R.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998;98:946-952.
3. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL: ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices-Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 2002;40: 1703-1719
4. Dijkman B, Wellens HJ: Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000;11:1196-1205.
5. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS, Hammill SC: Atrial therapies reduce atrial arrhythmia burden in detibrillator patients. Circulation 2001;104:1023-1028.
6. Adler SW 2nd, Wolpert C, Warman EN, Musley SK, Koehler JL. Euler DE: Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001;104:887-892.
7. Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto GL, Boriani G, Miraglia F, De Santo T, Santini M: Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: The 7250 Dual Defibrillator Italian Registry. Eur Heart J 2001;3(Suppl):P25-P32
8. Disertori M, Padeletti L, Santini M, Dini P, Gasparini M, Inama G, Botto GL, Boriuni G, Capucci A, Ricci R, Gramigna L, Del Greco M, Grammatico A, Vimercati M: Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: The AT500 Italian Registry. Eur Heart J 2001;3(Suppl):P16-P24
9. Israel CW, Hugl B, Unterberg C, Lawo T, Kennis I, Hettrick D, Hohnloser SH, AT500 Verification Study Investigators: Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multi-center study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-1128.
10. Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R, Tuzi J, Wang W, Johnson LJ, Euler DE. ATTEST Investigators: The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926-1932.
11. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J. Radoslovich G, Lee KL, Lamas GA. MOST Investigators: Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003;107:1614-1619.
12. Rosenqvist M, Brandt J, Schuller H: Long-term pacing in sinus node disease: Effect of stimulation mode on cardiovascular mortality and morbidity. Am Heart J 1988;116:16-22.
13. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK: Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-1216.
14. Swerdlow CD, Schsls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD: Detection of atrial fibrillation and flutter by a dual-chamber implantable cardiovertcr-defibrillator. For the Worldwide Jewel AF Investigators. Circulation 2000;101:878-885.
15. Wilkoff BL, Kuhlkamp V, Volosin K, Ellenhogen K, Waldecker B, Kacet S, Gillberg JM, DeSouza CM: Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001;103:381-386.
16. Padeletti L, Purerfellner H, Adler SW, Waller TJ, Harvey M, Horvitz L, Holbrook R, Kempen K, Mugglin A, Hettrick DA, Worldwide ASPECT Investigators: Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14:119-1195.
17. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Durun A, Val-Mejias J, Mackall J, Gold M. Atrial Dynamic Overdrive Pacing Trial (ADOPT) Investigators: A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-633.
18. Boriani G, Biffi M, Padeletti L, Spampinato A, Botto GL, Pignalberi C, Grammatico A, Hettrick DA, De Seta F, Branzi A: Effects of consistent atrial pacing and atrial rate stabilization-two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome. Eur Heart J 2001;3:P7-P15
19. Hugl B, Israel CW, Unterberg C, Lawo T, Geller JC, Kennis IM, Euler DE, Koehler JL, Hettrick DA, AT500 Verification Study Investigators: Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: Effects on therapy efficacy and atrial tachyarrhythmia burden. Europace 2003;5:403-409.
20. Israel CW, Ehrlich JR, Gronefeld G, Klesius A, Lawo T, Lemke B, Hohnloser SH: Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: Insights from a study using a new implantable device. J Am Coll Cardiol 2001;38:355-363.
21. Khand AU, Cleland JG, Deedwania PC: Prevention of and medical therapy for atrial arrhythmias in heart failure. Heart Fail Rev 2002;7:267-283.
22. Hynes BJ, Luck JC, Wolbrette DL, Bhatta L, Khan M, Samii S, Nacearelli GV: Atrial fibrillation in patients with heart failure. Curr Opin Cardiol 2003;18:32-38.
23. AFFIRM First Antiarrhythmic Drug Substudy Investigators: Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003;42:20-29.
24. Ndrepepa G, Weber S, Karch MR, Schneider MA, Schreieck J J, Schomig A, Schmitt C: Electrophysiologic characteristics of the spontaneous onset and termination of atrial fibrillation. Am J Cardiol 2002;90:1215-1220.
25. Gillis AM, Unterberg-Buchwald C, Schmidinger H, Massimo S, Wolfe K, Kavaney DJ, Otterness MF, Hohnloser SH, GEM III AT Worldwide Investigators: Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002;40:1653-1659.
26. Boriani G, Biffi M, Diemherger I, Martignani C, Branzi A: Rate control in atrial fibrillation: Choice of treatment and assessment of efficacy. Drugs 2003;63:1489-1509.
27. Van Gelder IC, Magens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns H.I. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-1840.
28. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U, STAF Investigators: Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690-1696.
29. Krol RB, Saksena S, Prakash A: New devices and hybrid therapies and new devices for treatment of atrial fibrillation. J Interv Card Electrophysiol 2000;4:163-169.
30. Saksena S, Madan N: Hybrid therapy of atrial fibrillation: Algorithms and outcome. J Interv Card Electrophysiol 2003;9:235-247.
31. Boriani G, Biffi M, Martignani C, Luceri R, Bartolini P, Branzi A: Current clinical perspectives on implantable devices for atrial defibrillation. Curr Opin Cardiol 2002;17:82-89.
32. Tai CT, Chen SA, Feng AN, Yu WC, Chen YJ, Chang MS: Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: Insights into the mechanism of termination. Circulation 1998;97:1935-1945.
33. Wang Z, Page P, Nattel S: Mechanisms of flecainide's antiarrythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-287
34. Rensma PL, Allessie MA, Lammers WJ, Bonke FI, Schalij MJ: Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 1988;62:395-410.
35. Boriani G, Biffi M, Capucci A, Bronzetti G, Ayers GM, Zannoli R, Branzi A, Magnani B: Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol 1999;33:333-341.
36. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S: Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation 1993;88:1030-1044.
37. Wijffels MC, Dorland R, Mast F, Allessie MA: Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 2000;102:260-267.
38. Biffi M, Boriani G, Bronzetti G, Capucci A, Branzi A, Magnani B: Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart 1999;82:176-182.
39. Daoud EG, Hummel JD, Augostini R, Williams S, Kalbfleisch SJ: Effect of verapamil on immediate recurrence of atrial fibrillation. J Cardiovasc Electrophysiol 2000;11:1231-1237.
40. Israel CW, Ehrlich JR, Gronefeld G, Li YG, Hohnloser SH: Immediate reinitiation of atrial tachyarrhythmias after spontaneous restoration of sinus rhythm in patients with an implanted monitoring device. Pacing Clin Electrophysiol 2003;26:1317-1325.
41. Falk RH: Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992;117:141-150.
42. Blanc JJ, De Roy L, Mansourati J, Poezevara Y, Marcon JL, Schoels W, Hidden-Lucet F, Barnay C, PIPAF Investigators: Atrial pacing for prevention of atrial fibrillation: Assessment of simultaneously implemented algorithms. Europace 20046:371-379.
43. Kok LC, Ellenbogen KA: Device therapy for atrial fibrillation. Cardiol Clin 2004;22:71-86.